Maria Sklodowska Curie Children's Hospital
Also known as: Maria Sklodowska-Curie Institute - Oncology Center | Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice | Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology | Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, POLAND | M.Sklodowska-Curie Memorial, Dep of Lung and Thoracic Tumours, Warsaw | The Maria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology | The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1997Last known activity
Sep 30, 2022
Timeline
1990s
- Jun 1, 1992
Maria Sklodowska Curie Children's Hospital— Founded
Drugs by trial phase (24 distinct, 18 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
- axitinib
- autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine
- dendritic cell-idiotype-keyhole limpet hemocyanin vaccine
- doxorubicin
- paclitaxel
- hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine
- hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine
- Filgrastim
- l-dos47
- ifosfamide
- imiglucerase
- autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine
- melanoma peptide-pulsed dendritic cells
- cisplatin
- 177lu-dotatoc
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Fibrosarcoma
- Gastrointestinal Hemorrhage
- Gastrointestinal Stromal Tumors
- Gaucher Disease
- Hemorrhage
- Histiocytic Sarcoma
- Histiocytoma, Malignant Fibrous
- Hodgkin Disease
- Leiomyosarcoma
- Liposarcoma
- Liposarcoma, Myxoid
- Lung Neoplasms
- Lymphangiosarcoma
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanoma
- Multiple Myeloma
- Myosarcoma
- Neoplasms, Plasma Cell
- Nerve Sheath Neoplasms
- Neuroendocrine Tumors
- Neurofibrosarcoma
- Plasmacytoma
- Proctitis
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma, Synovial
Recent trials (22)
- NCT05271162Overall official - principal investigatorPhase 3Sep 30, 2022
- NCT05235737CollaboratorPhase 4Mar 1, 2022
- NCT04258956Lead sponsorPhase 2Apr 30, 2019
- NCT04194125CollaboratorPhase 2Feb 1, 2019
- NCT03651375Lead sponsorPhase 2Feb 11, 2017
- NCT02722733Reponsible party - principal investigatorPhase 3Mar 1, 2016
- NCT02722733Lead sponsorPhase 3Mar 1, 2016
- NCT01908621Lead sponsorPhase 3Mar 1, 2013
- NCT01549418Lead sponsorPhase 4Sep 1, 2012
- NCT01549418Reponsible party - principal investigatorPhase 4Sep 1, 2012
- NCT02340208Overall official - principal investigatorPhase 1/Phase 2May 1, 2012
- NCT01611727CollaboratorPhase 2Jul 1, 2007
- NCT01630226CollaboratorPhase 2Jun 1, 2007
- NCT00291850Overall official - principal investigatorPhase 2Jun 1, 2005
- NCT00391625Overall official - principal investigatorPhase 1/Phase 2Feb 1, 2005
Details
- Founded
- Bucharest, RO Jun 1, 1992
- Last known activity
- Sep 30, 2022